The Stem Cell Political Agenda
The politics of stem cells are reviewed within the context of the current U.S. presidential election.
October 17, 2008
The politics of stem cells are reviewed within the context of the current U.S. presidential election.
The stem cell company Neuralstem, Inc., announces the licensing of patents for the delivery of targeted spinal cord therapeutics.
European researchers have coaxed testicular sperm-producing cells into new cells that behave like embryonic stem cells.
Lured by the promise of financial profit, the pharmaceutical giant Pfizer joins the stem cell community.
At the start of a major conference, the man who first introduced embryonic stem cells to the world delivers a cautionary message.
Michael West, CEO of BioTime, Inc., schedules key stem cell licensing topics for conference call.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2024, Stem Cell Insitute Panama. All rights reserved.